Endometriosis, malaria & leukemia treatments: 5 FDA approvals this week

Here are the five latest drugs or medical devices approved by the FDA since July 20:

Advertisement

1. The Magtrace and Sentimag Magnetic Localization System is used to guide lymph node biopsies in breast cancer patients undergoing a mastectomy.

2. Orlissa is the first treatment approved for endometriosis in 10 years.

3.  Krintafel is a one-dose treatment to prevent malaria relapses.

4. Tibsovo tablets are used to treat relapsed or refractory acute myeloid leukemia in adult patients with a specific genetic mutation.

5. Pfizer’s Nivestym is a biosimilar version of Amgen’s Neupogen, both of which are used to boost white blood cell counts in cancer patients.

More articles on supply chain:
Reuters: Amazon in talks to buy Indian pharmacy chain
London drugmaker boosts injectable opioid supply for US hospitals amid shortage
Bayer pulls birth control implant Essure from US market: 5 things to know

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.